The research, funded by the British Heart Foundation and published in the journal Circulation, opens the prospect of treating the condition at the earliest stages.
Improvements With Guselkumab in Psoriatic Arthritis Seen Across All MDA Domains
At the American College of Rheumatology annual meeting, results from the phase IIIb COSMOS trial were presented that examined the association between patient- and physician-reported